Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-034437
Filing Date
2025-11-12
Accepted
2025-11-12 16:07:32
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcda20250930_10q.htm   iXBRL 10-Q 858242
2 EXHIBIT 31.1 ex_880983.htm EX-31.1 10543
3 EXHIBIT 31.2 ex_880982.htm EX-31.2 10342
4 EXHIBIT 32.1 ex_880981.htm EX-32.1 3797
5 EXHIBIT 32.2 ex_880980.htm EX-32.2 4243
  Complete submission text file 0001437749-25-034437.txt   4279511

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20250930.xsd EX-101.SCH 42788
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20250930_def.xml EX-101.DEF 268831
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20250930_lab.xml EX-101.LAB 235122
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20250930_pre.xml EX-101.PRE 299188
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcda-20250930_cal.xml EX-101.CAL 26466
63 EXTRACTED XBRL INSTANCE DOCUMENT bcda20250930_10q_htm.xml XML 610228
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38999 | Film No.: 251472688
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)